These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23219109)

  • 21. Antibody levels and immune memory 23 years after primary plasma-derived hepatitis B vaccination: results of a randomized placebo-controlled trial cohort from China where endemicity is high.
    Wu Q; Zhuang GH; Wang XL; Wang LR; Li N; Zhang M
    Vaccine; 2011 Mar; 29(12):2302-7. PubMed ID: 21277403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination.
    Zhu CL; Liu P; Chen T; Ni Z; Lu LL; Huang F; Lu J; Sun Z; Qu C
    Vaccine; 2011 Oct; 29(44):7835-41. PubMed ID: 21816197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Dynamic study on the anti-HBs level of immunized children born to HBsAg-positive and HBsAg-negative mothers in hyperendemic area of hepatitis B].
    Gong J; Li RC; Li YP; Yang JY; Chen XR; Nong Y; Huang ZN; Li Q; Liu CB; Zhuang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jan; 29(1):13-6. PubMed ID: 18785470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lamivudine monoprophylaxis for de novo HBV infection in HBsAg-negative recipients with HBcAb-positive liver grafts.
    Vizzini G; Gruttadauria S; Volpes R; D'Antoni A; Pietrosi G; Filì D; Petridis I; Pagano D; Tuzzolino F; Santonocito MM; Gridelli B
    Clin Transplant; 2011; 25(1):E77-81. PubMed ID: 21039887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of a bivalent Haemophilus influenzae type B-hepatitis B vaccine in preventing hepatitis B virus infection among children born to hepatitis B e antigen-positive carrier mothers.
    Doherty R; Garland S; Wright M; Bulotsky M; Liss C; Lakkis H; Nikas A; Straus W
    Pediatr Infect Dis J; 2009 Sep; 28(9):777-81. PubMed ID: 19636283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Twelve-year follow-up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine versus plasma-derived vaccine without booster doses in children.
    Yuen MF; Lim WL; Cheng CC; Lam SK; Lai CL
    Hepatology; 1999 Mar; 29(3):924-7. PubMed ID: 10051499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccination against hepatitis B in liver transplant recipients: pilot analysis of cellular immune response shows evidence of HBsAg-specific regulatory T cells.
    Bauer T; Günther M; Bienzle U; Neuhaus R; Jilg W
    Liver Transpl; 2007 Mar; 13(3):434-42. PubMed ID: 17318860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular and humoral immune responses induced by intradermal or intramuscular vaccination with the major hepatitis B surface antigen.
    Rahman F; Dahmen A; Herzog-Hauff S; Böcher WO; Galle PR; Löhr HF
    Hepatology; 2000 Feb; 31(2):521-7. PubMed ID: 10655280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maintenance of immune memory to the hepatitis B envelope protein following adoptive transfer of immunity in bone marrow transplant recipients.
    Ilan Y; Nagler A; Zeira E; Adler R; Slavin S; Shouval D
    Bone Marrow Transplant; 2000 Sep; 26(6):633-8. PubMed ID: 11035369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years.
    Hammitt LL; Hennessy TW; Fiore AE; Zanis C; Hummel KB; Dunaway E; Bulkow L; McMahon BJ
    Vaccine; 2007 Sep; 25(39-40):6958-64. PubMed ID: 17714836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
    Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
    Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Are teenagers immunized in infancy still protected against hepatitis B?].
    Pokorska-Lis M; Marczyńska M
    Przegl Lek; 2010; 67(1):13-7. PubMed ID: 20509565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intramuscular versus low-dose intradermal hepatitis B vaccine. Assessment by humoral and cellular immune response to hepatitis B surface antigen.
    Frazer IH; Jones B; Dimitrakakis M; Mackay IR
    Med J Aust; 1987 Mar; 146(5):242-5. PubMed ID: 2950303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extended HBV vaccination in liver transplant recipients for HBV-related cirrhosis: report of two successful cases.
    Di Paolo D; Lenci I; Trinito MO; Tisone G; Angelico M
    Dig Liver Dis; 2005 Oct; 37(10):793-8. PubMed ID: 16024302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of liver transplantation from hepatitis B core antibody-positive donors in viral cirrhosis patients: the prevailing negative effect of recipient hepatitis C virus infection.
    Tandoi F; Romagnoli R; Martini S; Mazza E; Nada E; Cocchis D; Lupo F; Salizzoni M
    Transplant Proc; 2012 Sep; 44(7):1963-5. PubMed ID: 22974883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.
    Yu AS; Vierling JM; Colquhoun SD; Arnaout WS; Chan CK; Khanafshar E; Geller SA; Nichols WS; Fong TL
    Liver Transpl; 2001 Jun; 7(6):513-7. PubMed ID: 11443579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term benefit of hepatitis B vaccination among children in Thailand with transient hepatitis B virus infection who were born to hepatitis B surface antigen-positive mothers.
    Poovorawan Y; Chongsrisawat V; Theamboonlers A; Srinivasa K; Hutagalung Y; Bock HL; Hoet B
    J Infect Dis; 2009 Jul; 200(1):33-8. PubMed ID: 19473096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A study of the efficacy and safety of using hepatitis B surface antigen-positive donors for liver transplantation].
    Ju WQ; He XS; Wang DP; Deng RH; Wu LW; Guo ZY; Zhu XF; Huang JF
    Zhonghua Gan Zang Bing Za Zhi; 2012 Jan; 20(1):14-6. PubMed ID: 22464699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of antibody to hepatitis B surface antigen after liver transplantation for chronic hepatitis B.
    Lo CM; Fung JT; Lau GK; Liu CL; Cheung ST; Lai CL; Fan ST; Wong J
    Hepatology; 2003 Jan; 37(1):36-43. PubMed ID: 12500186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan's national hepatitis B vaccination programme.
    Su FH; Chen JD; Cheng SH; Sung KY; Jeng JJ; Chu FY
    J Viral Hepat; 2008 Jan; 15(1):14-9. PubMed ID: 18088240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.